CELLPHIRE, INC.

Profile

Company Names

CELLPHIRE, INC.

Addresses

9430 KEY WEST AVENUE, SUITE 250, ROCKVILLE, MD 20850

Phone Numbers

240-268-2489

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$5,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-11-26 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
1
2023-09-19 
$2,000,000.00 
$8,000,000.00 
$6,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAMELA 
 
CONLEY 
DIRECTOR
CELLPHIRE, INC.
THOMAS 
 
DUBIN 
DIRECTOR
CELLPHIRE, INC.
MICHAEL 
 
GAFFNEY 
EXECUTIVE OFFICER, DIRECTOR
EVERCO, INC.   |  INTOUCH INSIGHT LTD.   |  CELLPHIRE, INC.
DAVID 
 
HIRSH 
DIRECTOR
M+H MCCANDLESS SQUARE SENIOR LIVING LLC   |  HSL EAST BROAD INVESTOR LLC   |  M+H HOTEL FUND 1 LLC   |  M+H UA FUND LLC   |  M+H MULTIFAMILY PE FUND LLC   |  CELLPHIRE, INC.   |  M+H SELECT SERVICE HOTEL FUND LLC
ANGELA 
 
HOWERTON 
EXECUTIVE OFFICER
CELLPHIRE, INC.
RAFAEL 
 
JORDA 
DIRECTOR
CELLPHIRE, INC.
JAMES 
 
PEAKE 
DIRECTOR
BRAINSCOPE COMPANY, INC.   |  CELLPHIRE, INC.
RANDALL 
 
STANICKY 
DIRECTOR
CLICK THERAPEUTICS, INC.   |  CELLPHIRE, INC.
CRISTIANE 
 
WOLFE 
EXECUTIVE OFFICER
CELLPHIRE, INC.
DEREK 
 
WOODS 
DIRECTOR
CELLPHIRE, INC.
ROB 
 
WOODS 
EXECUTIVE OFFICER
RESIDENTIAL REAL ESTATE TOTAL RETURN OPPORTUNITIES FUND LP   |  CELLPHIRE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-11-26 
2023-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-09-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#